Clinical Trial Update: An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating AGS-009 in systemic lupus erythematosus has completed its status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• AGS-009

Snippet

Sponsor: Argos Therapeutics | Conditions: Inflammation, Systemic Lupus Erythematosus (SLE) | Phase 1 | Status: COMPLETED